Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Kyverna Therapeutics Inc (NASDAQ: KYTX) was $7.19 for the day, up 2.71% from the previous closing price of $7.0. In other words, the price has increased by $2.71 from its previous closing price. On the day, 2.24 million shares were traded. KYTX stock price reached its highest trading level at $7.4 during the session, while it also had its lowest trading level at $7.02.
Ratios:
Our analysis of KYTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.16 and its Current Ratio is at 5.16. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
On May 27, 2025, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5. On October 10, 2024, UBS started tracking the stock assigning a Buy rating and target price of $13.UBS initiated its Buy rating on October 10, 2024, with a $13 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 15 ’25 when Walker Karen Marie sold 23,998 shares for $12.20 per share. The transaction valued at 292,776 led to the insider holds 22,636 shares of the business.
KAREN WALKER bought 23,998 shares of KYTX for $210,702 on Dec 15 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYTX now has a Market Capitalization of 428571488 and an Enterprise Value of 148780464.
Stock Price History:
The Beta on a monthly basis for KYTX is 3.66, which has changed by 0.8341837 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, KYTX has reached a high of $13.67, while it has fallen to a 52-week low of $1.78. The 50-Day Moving Average of the stock is -2.41%, while the 200-Day Moving Average is calculated to be 66.95%.
Shares Statistics:
KYTX traded an average of 1.32M shares per day over the past three months and 4626270 shares per day over the past ten days. A total of 43.79M shares are outstanding, with a floating share count of 21.91M. Insiders hold about 49.98% of the company’s shares, while institutions hold 30.70% stake in the company. Shares short for KYTX as of 1764288000 were 3530429 with a Short Ratio of 2.67, compared to 1761868800 on 2696732. Therefore, it implies a Short% of Shares Outstanding of 3530429 and a Short% of Float of 13.900000000000002.
Earnings Estimates
The dynamic stock of Kyverna Therapeutics Inc (KYTX) is currently being evaluated by a team of 5.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.89, with high estimates of -$0.86 and low estimates of -$0.92.
Analysts are recommending an EPS of between -$3.65 and -$4.01 for the fiscal current year, implying an average EPS of -$3.76. EPS for the following year is -$3.59, with 5.0 analysts recommending between -$3.25 and -$3.81.
